<- Go Home
LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Market Cap
$101.6M
Volume
75.4K
Cash and Equivalents
$13.6M
EBITDA
-$3.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$29.1M
Profit Margin
48.34%
52 Week High
$12.96
52 Week Low
$4.95
Dividend
N/A
Price / Book Value
6.81
Price / Earnings
15.64
Price / Tangible Book Value
9.99
Enterprise Value
$104.2M
Enterprise Value / EBITDA
-37.40
Operating Income
-$8.1M
Return on Equity
357.30%
Return on Assets
-7.26
Cash and Short Term Investments
$13.6M
Debt
$2.4M
Equity
$28.7M
Revenue
$60.3M
Unlevered FCF
N/A
Sector
Health Care Equipment and Supplies
Category
N/A